Genome-Wide expression studies of blood and lymphoblastoid cell lines in autism spectrum disorders

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

mRNA and miRNA expression studies of blood and lymphoblastoid cell lines derived from individuals with autism spectrum disorder (ASD) have shown few genes that are shared between studies. Some that have been replicated in at least three studies include: BTG1, HOOK3, FCGBP, REV3L, CCDC47 and MAP4, all of which are implicated in cell proliferation. Pathways that have been replicated in at least two studies include: mTOR, neurotrophin signaling, actin cytoskeleton/ILK signaling, VEGF and Natural Killer cell signaling. Abnormalities of mTOR signaling are implicated in idiopathic ASD as well as in genetic syndromes associated with ASD, including Fragile X, TSC1, TSC2, NF-1 and PTEN. This chapter reviews the results of gene expression studies on blood, lymphoblastoid cell lines, and brain tissues that, despite the lack of shared genes, reveal pathways common to subgroups of idiopathic and genetic cases of ASD, and suggests that a Pathway-Oriented approach may identify better treatment targets.

Original languageEnglish (US)
Title of host publicationFrontiers in Autism Research: New Horizons for Diagnosis and Treatment
PublisherWorld Scientific Publishing Co.
Pages147-173
Number of pages27
ISBN (Electronic)9789814602167
ISBN (Print)9789814602150
DOIs
StatePublished - Jan 1 2014

Fingerprint

Blood Cells
Blood
Genes
Cells
Genome
Cell Line
Cell signaling
Nerve Growth Factors
Cell proliferation
MicroRNAs
Gene expression
Vascular Endothelial Growth Factor A
Actins
Brain
Actin Cytoskeleton
Natural Killer Cells
Tissue
Messenger RNA
Cell Proliferation
Gene Expression

Keywords

  • Alternative splicing
  • Autism
  • Blood
  • Gene expression
  • Leukocytes
  • Lymphoblastoid cell lines
  • Microarrays
  • microRNA
  • Pathways
  • RNA expression

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)
  • Neuroscience(all)

Cite this

Stamova, B., & Sharp, F. R. (2014). Genome-Wide expression studies of blood and lymphoblastoid cell lines in autism spectrum disorders. In Frontiers in Autism Research: New Horizons for Diagnosis and Treatment (pp. 147-173). World Scientific Publishing Co.. https://doi.org/10.1142/9789814602167_0007

Genome-Wide expression studies of blood and lymphoblastoid cell lines in autism spectrum disorders. / Stamova, Boryana; Sharp, Frank R.

Frontiers in Autism Research: New Horizons for Diagnosis and Treatment. World Scientific Publishing Co., 2014. p. 147-173.

Research output: Chapter in Book/Report/Conference proceedingChapter

Stamova, B & Sharp, FR 2014, Genome-Wide expression studies of blood and lymphoblastoid cell lines in autism spectrum disorders. in Frontiers in Autism Research: New Horizons for Diagnosis and Treatment. World Scientific Publishing Co., pp. 147-173. https://doi.org/10.1142/9789814602167_0007
Stamova B, Sharp FR. Genome-Wide expression studies of blood and lymphoblastoid cell lines in autism spectrum disorders. In Frontiers in Autism Research: New Horizons for Diagnosis and Treatment. World Scientific Publishing Co. 2014. p. 147-173 https://doi.org/10.1142/9789814602167_0007
Stamova, Boryana ; Sharp, Frank R. / Genome-Wide expression studies of blood and lymphoblastoid cell lines in autism spectrum disorders. Frontiers in Autism Research: New Horizons for Diagnosis and Treatment. World Scientific Publishing Co., 2014. pp. 147-173
@inbook{b55963a6bb5c449eba7ab2a50f7582ad,
title = "Genome-Wide expression studies of blood and lymphoblastoid cell lines in autism spectrum disorders",
abstract = "mRNA and miRNA expression studies of blood and lymphoblastoid cell lines derived from individuals with autism spectrum disorder (ASD) have shown few genes that are shared between studies. Some that have been replicated in at least three studies include: BTG1, HOOK3, FCGBP, REV3L, CCDC47 and MAP4, all of which are implicated in cell proliferation. Pathways that have been replicated in at least two studies include: mTOR, neurotrophin signaling, actin cytoskeleton/ILK signaling, VEGF and Natural Killer cell signaling. Abnormalities of mTOR signaling are implicated in idiopathic ASD as well as in genetic syndromes associated with ASD, including Fragile X, TSC1, TSC2, NF-1 and PTEN. This chapter reviews the results of gene expression studies on blood, lymphoblastoid cell lines, and brain tissues that, despite the lack of shared genes, reveal pathways common to subgroups of idiopathic and genetic cases of ASD, and suggests that a Pathway-Oriented approach may identify better treatment targets.",
keywords = "Alternative splicing, Autism, Blood, Gene expression, Leukocytes, Lymphoblastoid cell lines, Microarrays, microRNA, Pathways, RNA expression",
author = "Boryana Stamova and Sharp, {Frank R}",
year = "2014",
month = "1",
day = "1",
doi = "10.1142/9789814602167_0007",
language = "English (US)",
isbn = "9789814602150",
pages = "147--173",
booktitle = "Frontiers in Autism Research: New Horizons for Diagnosis and Treatment",
publisher = "World Scientific Publishing Co.",
address = "United States",

}

TY - CHAP

T1 - Genome-Wide expression studies of blood and lymphoblastoid cell lines in autism spectrum disorders

AU - Stamova, Boryana

AU - Sharp, Frank R

PY - 2014/1/1

Y1 - 2014/1/1

N2 - mRNA and miRNA expression studies of blood and lymphoblastoid cell lines derived from individuals with autism spectrum disorder (ASD) have shown few genes that are shared between studies. Some that have been replicated in at least three studies include: BTG1, HOOK3, FCGBP, REV3L, CCDC47 and MAP4, all of which are implicated in cell proliferation. Pathways that have been replicated in at least two studies include: mTOR, neurotrophin signaling, actin cytoskeleton/ILK signaling, VEGF and Natural Killer cell signaling. Abnormalities of mTOR signaling are implicated in idiopathic ASD as well as in genetic syndromes associated with ASD, including Fragile X, TSC1, TSC2, NF-1 and PTEN. This chapter reviews the results of gene expression studies on blood, lymphoblastoid cell lines, and brain tissues that, despite the lack of shared genes, reveal pathways common to subgroups of idiopathic and genetic cases of ASD, and suggests that a Pathway-Oriented approach may identify better treatment targets.

AB - mRNA and miRNA expression studies of blood and lymphoblastoid cell lines derived from individuals with autism spectrum disorder (ASD) have shown few genes that are shared between studies. Some that have been replicated in at least three studies include: BTG1, HOOK3, FCGBP, REV3L, CCDC47 and MAP4, all of which are implicated in cell proliferation. Pathways that have been replicated in at least two studies include: mTOR, neurotrophin signaling, actin cytoskeleton/ILK signaling, VEGF and Natural Killer cell signaling. Abnormalities of mTOR signaling are implicated in idiopathic ASD as well as in genetic syndromes associated with ASD, including Fragile X, TSC1, TSC2, NF-1 and PTEN. This chapter reviews the results of gene expression studies on blood, lymphoblastoid cell lines, and brain tissues that, despite the lack of shared genes, reveal pathways common to subgroups of idiopathic and genetic cases of ASD, and suggests that a Pathway-Oriented approach may identify better treatment targets.

KW - Alternative splicing

KW - Autism

KW - Blood

KW - Gene expression

KW - Leukocytes

KW - Lymphoblastoid cell lines

KW - Microarrays

KW - microRNA

KW - Pathways

KW - RNA expression

UR - http://www.scopus.com/inward/record.url?scp=84969674513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969674513&partnerID=8YFLogxK

U2 - 10.1142/9789814602167_0007

DO - 10.1142/9789814602167_0007

M3 - Chapter

AN - SCOPUS:84969674513

SN - 9789814602150

SP - 147

EP - 173

BT - Frontiers in Autism Research: New Horizons for Diagnosis and Treatment

PB - World Scientific Publishing Co.

ER -